EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease

Wei Wuli iD, Hsueh-Hui Yang, Tzyy-Wen Chiou, Peng Yeong Woon iD, Yue-Xuan Xu, Cynthia Tjandra iD, Ivan Wijaya, Horng-Jyh Harn, Shinn-Zong Lin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Wei Wuli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan. Hauptthemen laut MEDLINE: Alzheimer Disease, Mesenchymal Stem Cells, Left-Right Determination Factors, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Gwo Xi Stem Cell Applied Technology Co., Ltd, Gwo Xi Stem Cell Applied Technology Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose-derived mesenchymal stem cells (ADSCs) have exhibited promising therapeutic potential in Alzheimer’s disease (AD), although the underlying mechanisms remain poorly understood. Previously established Alzheimer’s disease neuron models derived from Ts21-induced pluripotent stem cells (Ts21-iPSCs) have been shown to exhibit progressive amyloid beta accumulation during neuronal differentiation. In this study, we employed a Transwell co-culture system to investigate the interaction between neurons derived from Ts21-iPSCs and ADSCs. Our findings revealed that co-culture with ADSCs significantly enhanced the survival rate of AD neurons. Proteomics analysis identified significant upregulation of left–right determination factor 2 (LEFTY2) protein in the co-culture medium. Supplementation with 2 nM LEFTY2 markedly improved the survival and growth of AD neurons. Furthermore, LEFTY2 effectively downregulates the expression of apolipoprotein E4 and amyloid beta 1–42, along with attenuating phosphorylated tau231 levels in AD neurons. These results suggest the potential of LEFTY2 as a promising therapeutic candidate for Alzheimer’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMesenchymal Stem CellsLeft-Right Determination FactorsAdipose TissueHumansNeuronsAmyloid beta-PeptidesCoculture TechniquesInduced Pluripotent Stem Cellstau ProteinsCell DifferentiationApolipoprotein E4Cell SurvivalPeptide FragmentsCells, Cultured

Stichwörter der Autor:innen

Alzheimer’s diseaseTs21 induced pluripotent stem cellsadipose derived mesenchymal stem cellsapolipoprotein E4left–right determination factor 2

Substanzen

Amyloid beta-PeptidesLeft-Right Determination Factorstau ProteinsApolipoprotein E4amyloid beta-protein (1-42)Peptide Fragments

Autor:innen und Institutionen

  • Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan.
  • Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan.
  • Department of Life Science, National Dong Hwa University, Hualien 974301, Taiwan.
  • Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 97004, Taiwan.
  • Department of Pathology, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan.
  • Department of Neurology, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan.

ORCID-Profile: Wei Wuli, Peng Yeong Woon, Cynthia Tjandra, Shinn-Zong Lin

Förderung

  • National Science and Technology Council
  • Gwo Xi Stem Cell Applied Technology Co., Ltd
  • Gwo Xi Stem Cell Applied Technology Co., Ltd.

Zitieren

APA

Wuli, W., Yang, H. H., Chiou, T. W., Woon, P. Y., Xu, Y. X., Tjandra, C., Wijaya, I., Harn, H. J., & Lin, S. Z. (2025). The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073382

Vancouver

Wuli W, Yang HH, Chiou TW, Woon PY, Xu YX, Tjandra C, et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073382

BibTeX
@article{Wuli2025,
  author = {Wuli, Wei and Yang, Hsueh-Hui and Chiou, Tzyy-Wen and Woon, Peng Yeong and Xu, Yue-Xuan and Tjandra, Cynthia and Wijaya, Ivan and Harn, Horng-Jyh and Lin, Shinn-Zong},
  title = {The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073382}
}
Kostenlos starten →